Site Search
Search Results
Access to Biomarker Testing
Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Massachusetts residents can benefit from this important testing. Not all communities are benefiting from the latest advancements in biomarker testing and precision medicine. Communities that have been excluded, including communities of color, individuals with lower socioeconomic ...
Expand Access to Biomarker Testing in Massachusetts
Welcome! Biomarker testing helps connect patients with the right treatment at the right time. ACS CAN and partners are working together to make sure more Massachusetts residents can benefit from this important testing. Video of maggies_biomarker_story What is Biomarker Testing? In cancer care, biomarkers are often used to help determine the best treatment for a patient . A “ ...
Legislation to Increase Access to Biomarker Testing Receives Favorable Committee Report
BOSTON - Today, the Joint Committee on Financial Services reported legislation to expand access to guideline indicated biomarker testing, favorably out of committee. The bills, S.689 and H.1074, An Act relative to patient access to biomarker testing to provide appropriate therapy , sponsored by Senator Susan Moran and Representative Meg Kilcoyne, would increase access to ...
Cancer Advocates to Convene on Beacon Hill to Urge Lawmakers to Reduce Health Disparities
... Advocates will ask lawmakers to support legislation (House Bill 1227/Senate Bill 809) that would ensure insurance coverage of comprehensive biomarker testing , which uses information about a person’s own genes or proteins to prevent, diagnose or treat diseases like cancer. Unfortunately, not all communities are benefiting from the latest advancements in biomarker testing and precision medicine due to financial barriers. Improving coverage for biomarker testing across insurance types will help ...
ACS CAN 2023 Massachusetts State Legislative Priorities
... products. We will be making the following fact-based policies a priority and ask for your support: Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Not all communities are benefiting from the latest advancements in biomarker testing and precision medicine. Communities that ...
ACS CAN 2024 Massachusetts State Legislative Priorities
... products. We will be making the following fact-based policies a priority and ask for your support: Ensuring Access to Quality Care Access to Biomarker Testing: ACS CAN will advocate for improved coverage of comprehensive biomarker testing. Not all communities are benefiting from the latest advancements in biomarker testing and precision medicine. Communities that ...
2025-2026 Massachusetts Priorities
Connecting Patients with the Right Treatment at the Right Time Treatment with targeted therapy often requires diagnostic testing to analyze biological samples (e.g., blood, tumor tissue) taken from a patient to identify and evaluate specific biomarkers. Research shows ... treatment for their cancer, patients can avoid treatments that will be ineffective or have more adverse side effects. Insurance coverage for biomarker testing is failing to keep pace with innovations and advancements in treatment. We must work to dismantle barriers that prevent all patients from benefiting from biomarker testing and precision medicine. Expanding Access to Patient Navigation Navigating the healthcare system can be confusing and ...
Volunteer Spotlight: Jung A Han
... many doctors, nurses and researchers have given me. I was definitely feeling lost. Then I found ACS CAN. Massachusetts initiated the Access to Biomarker bill the same month I joined. It seemed like a match made in heaven. Since then, my story and this work have uplifted my spirits and ... In the meantime, I will continue to tell my story so that our voices can be heard. You have been a story teller as part of the Massachusetts biomarker campaign. Can you tell me more about they different ways you've been telling your story and why you're advocating more for other patients ... a cancer survivor who was diagnosed with Stage 3 metastatic non-small cell lung cancer after a delayed diagnosis due to the pandemic. Biomarker testing revealed an ALK mutation, which changed my treatment from standard chemotherapy or immunotherapy to an FDA-approved oral medication that ...
2023-2024 ACS CAN Massachusetts Priority Bills Filed
... Here are the bill names, current bill numbers, and lead legislative sponsors for each of our bills: An Act relative to cancer patient access to biomarker testing - SD 1687 - Sen. Susan Moran & HD 2413 - Rep. Meghan Kilcoyne An Act empowering health care consumers - SD 625 - Sen. Brendan Crighton & ...
Type
Priority Issue
State
- (-) Remove Massachusetts filter Massachusetts